A Clinical Study of Enlicitide in Participants With Severe Renal Impairment (MK-0616-032)
Public ClinicalTrials.gov record NCT06643377. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multiple-Dose Clinical Study to Evaluate the Pharmacokinetics of Enlicitide in Participants With Severe Renal Impairment
Study identification
- NCT ID
- NCT06643377
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Enrollment
- 27 participants
Conditions and interventions
Conditions
Interventions
- Enlicitide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 21, 2024
- Primary completion
- Jun 24, 2025
- Completion
- Jun 24, 2025
- Last update posted
- Jul 22, 2025
2024 – 2025
United States locations
- U.S. sites
- 5
- U.S. states
- 1
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Velocity Clinical Research, New Smyrna Beach ( Site 0003) | Edgewater | Florida | 32132 | — |
| Velocity Clinical Research, Hallandale Beach ( Site 0006) | Hallandale | Florida | 33009 | — |
| Nature Coast Clinical Research - Inverness ( Site 0002) | Inverness | Florida | 34452 | — |
| Jacksonville Center for Clinical Research ( Site 0004) | Jacksonville | Florida | 32216 | — |
| Genesis Clinical Research, LLC ( Site 0001) | Tampa | Florida | 33603 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06643377, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 22, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06643377 live on ClinicalTrials.gov.